Trial Profile
Quality of Life in Asthma and Rhinitis Allergic With Singulair
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 May 2022
Price :
$35
*
At a glance
- Drugs Montelukast (Primary)
- Indications Allergic rhinitis; Asthma
- Focus Therapeutic Use
- Sponsors Merck & Co; Merck Sharp & Dohme
- 17 Nov 2006 New trial record.